Rexulti (brexiprazole) is highly similar to Abilify, another antipsychotic drug from Otsuka Pharmaceuticals that is linked to gambling addiction and other compulsive behavior disorders.
Rexulti and Abilify
Rexulti® is an antipsychotic medication that is sold by Otsuka Pharmaceutical Co. Ltd of Tokyo — the same manufacturer of another antipsychotic drug called Abilify (aripiprazole). Around the same time Abilify lost patent protection, drug-makers created a similar medication called brexpiprazole and sold it under the Rexulti brand-name.
Rexulti and Gambling Addiction
Rexulti and Abilify are highly similar medications. They are both used to treat severe mood disorders like schizophrenia. Likewise, they may have a similar risk of compulsive behavior side effects. The label on Rexulti recommends talking to a doctor if you have a history of gambling addiction. The label also warns about cases of “pathological gambling” and other impulse-control disorders with similar drugs.
FDA Warnings for Abilify
In May 2016, the FDA warned that Abilify side effects include uncontrollable urges to gamble, eat, shop, and have sex. These impulse-control disorders can have a devastating effect on a person’s livelihood and relationships.
The label on Abilify also warns that patients may not recognize that their addictive behaviors are abnormal. This is why it is essential that doctors specifically ask about any new or intense urges to gamble, eat, shop, or have sex. Patients may need to stop taking Abilify.